# P-01 Commercial TTP — Technology Transfer Package (R289)

## Page One: Three Boxes

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                          WHAT IS KNOWN                                       │
│                                                                             │
│  225-run computational ablation (5 seeds × 5 arms × 9 attacks)              │
│  Rate limiting is the dominant mechanism (41/45 runs confirm criticality)   │
│  V2.1 beats existing closed-loop by 2.1-2.9x across 9 attack modes          │
│  Multi_failure is the known catastrophic boundary (peak 69.8 mmHg)          │
│  Full provenance manifest (commits, hashes, seeds documented)               │
│  Prior art landscape disclosed (US20210338992A1, US20260115436A1, etc.)    │
└─────────────────────────────────────────────────────────────────────────────┘

┌─────────────────────────────────────────────────────────────────────────────┐
│                        WHAT IS HYPOTHESIZED                                  │
│                                                                             │
│  Physical bench will reproduce the 2-3x computational advantage             │
│  The bounded-rate mechanism creates a different robustness envelope         │
│  under sensor uncertainty that is NOT produced by existing approaches       │
│  The economic value (avoided shunt revisions) justifies the package price   │
└─────────────────────────────────────────────────────────────────────────────┘

┌─────────────────────────────────────────────────────────────────────────────┐
│                       WHAT THE BUYER CAN TEST                               │
│                                                                             │
│  80-run blinded physical protocol (B vs V2.1)                               │
│  8 attack modes + multi_failure boundary                                    │
│  Primary endpoint: time-to-critical hydraulic state under sensor noise      │
│  Secondary: peak ICP, time outside envelope, flow preserved, overshoot,     │
│  recovery time, actuation frequency                                         │
│  Designed to DISPROVE the computational result (±30% falsification)        │
│  Complete BOM ($7-10K), assembly instructions, software, calibration        │
└─────────────────────────────────────────────────────────────────────────────┘
```

## The Commercial Argument

**Existing technology provides:** physiologic feedback, closed-loop regulation, obstruction detection, flow regulation, sensor-failure handling and fallback.

**Our proposed contribution:** a particular bounded-rate multi-segment conductance-control regime that, in our computational tests, appears to produce a materially different robustness envelope under sensor uncertainty.

**The argument:** We are NOT claiming we invented closed-loop shunt control, sensor-failure fallback, or flow regulation. We are claiming that the specific combination of bounded conductance-rate (2%/sec) + multi-segment continuous redistribution produces a measurable robustness advantage (2-3x across 9 attack modes, confirmed by 225-run ablation) that existing approaches do not achieve.

## The Mechanism

**Rate-Limited Physiologic Conductance Control for Multi-Segment CSF Drainage**

```
physiologic sensing → desired conductance → bounded conductance slew (2%/sec) → continuous redistribution → hydraulic response
```

NOT: AI → prediction → smart valve.

## What the Buyer Receives

1. **Frozen mechanism** (FROZEN_COMMERCIAL_MECHANISM_R289.json)
2. **225-run ablation data** (p01_R282_ablation_5seeds.json + 19_ablation_COMPLETE_findings_R288.md)
3. **180-run canonical comparison** (p01_R285_CANONICAL_decisive_comparison.json)
4. **Complete prototype BOM** (PROTOTYPE_BOM_R289_BUILDABLE.json — $7-10K, all COTS)
5. **Physical bench protocol** (PHYSICAL_BENCH_PROTOCOL_R284_COMMERCIAL.json — 80-run blinded)
6. **Prior art landscape** (PRIOR_ART_LANDSCAPE_R287.json — honest disclosure)
7. **Provenance manifest** (DATASET_PROVENANCE_MANIFEST.json — every run traced)
8. **Controller software** (Python, open source, no dependencies)
9. **Cross-domain research** (mechanism generalizable to vascular, dialysis, infusion, respiratory)

## The Ask

> "We developed a bounded-rate conductance-control approach for multi-segment CSF drainage. In our 225-run ablation the rate-limiting mechanism is the dominant contributor to the simulated advantage. We have a blinded physical protocol designed specifically to falsify the computational result. We'd like your engineering team to try to break it."

**This is a technical evaluation, not a transaction.**

## Pricing

**$50K or $500K buyer receives the same complete package.** The price changes rights and scope (exclusivity, field-of-use, territory, customization, support), NOT evidence quality.

The buyer's engineering team evaluates the technology. Their objections become machine-readable evidence that feeds the next iteration. Whether they confirm or break our computational result, the buyer generates value — either a validated technology asset or a high-quality negative result.
